Abiraterone for prostate cancer not previously treated with hormone therapy

N. D. James*, J. S. De Bono, M. R. Spears, N. W. Clarke, M. D. Mason, D. P. Dearnaley, A. W.S. Ritchie, C. L. Amos, C. Gilson, R. J. Jones, D. Matheson, R. Millman, G. Attard, S. Chowdhury, W. R. Cross, S. Gillessen, C. C. Parker, J. M. Russell, D. R. Berthold, C. BrawleyF. Adab, S. Aung, A. J. Birtle, J. Bowen, S. Brock, P. Chakraborti, C. Ferguson, J. Gale, E. Gray, M. Hingorani, P. J. Hoskin, J. F. Lester, Z. I. Malik, F. McKinna, N. McPhail, J. Money-Kyrle, J. O'Sullivan, O. Parikh, A. Protheroe, A. Robinson, N. N. Srihari, J. Wagstaff, J. Wylie, A. Zarkar, M. K.B. Parmar, M. R. Sydes, Carys W Thomas

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

753 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Abiraterone for prostate cancer not previously treated with hormone therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences